The term "mycoplasma" refers to a genus of bacteria usually found in cell culture. These bacteria lack a cell wall more correctly known as mollicutes, making them resistant to widely used antibiotics, such as penicillin. Mycoplasma testing labs is quickly transmitted by droplets during cell culture and can persist in dry form for months. Contamination of mycoplasma is challenging to see with a microscope and requires complex tests to be identified. Contamination may have a profound impact on experimental work. Depending on the species present, mycoplasma organisms may affect cell growth, metabolism, tumorigenicity, and the response to chemotherapy.
As per Market Research Future (MRFR) analysis, the global mycoplasma testing market is estimated to expand significantly over the forecast period. The global mycoplasma testing kit market held a market value of USD 514 million in 2017 and is anticipated to grow at a CAGR of 11.6% from forecast period.
Increasing research and development efforts have resulted in higher revenues for the global market for mycoplasma testing services. Some of the major players on the market are also investing a tremendous amount of money in this market to come up with advanced and better solutions to deliver to their customers. In addition, growing expenditure in the healthcare sector and increasing research in life science are expected to generate lucrative growth opportunities in this market.
Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6776
Segmentation:
The global market for mycoplasma testing has been segmented into product, technique, application, and end-user.
By Product
- Kits & reagents
- Instruments
- Services
By Technique
- Kits DNA Stain
- Enzyme-based
- PCR
- ELISA
- Direct Assay
- Indirect Assay
- Others
By Application
- Kits cell line
- Cell therapy testing
- Virus testing
- Row material testing
- Lot release testing
- Others
By End-user
- Kits pharmaceutical
- Biological manufacturing
- Contract research organizations
- Cell banks
- Others
Key Players
Some of the significant participants in the global mycoplasma testing market are
- Charles River Laboratories, Inc.
- Merck KGaA
- Lonza Group Ltd
- Roche Diagnostics
- SGS S.A.
- American Type Culture Collection
- Invivogen, Wuxi Apptec
- Thermo Fisher Scientific Inc.
- Promocell GmbH
Regional Analysis
Regionally, the global market for mycoplasma testing segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.
Geographically, the Americas are expected to dominate the global market for mycoplasma testing due to a well-established players and rising R&D costs.
Europe is set to retain the second-largest position in the global market for mycoplasma testing. The growth of the market in this area is due to the development of the pharmaceutical and medical device industries.
Get Access Full Report @ https://www.marketresearchfuture.com/reports/mycoplasma-testing-market-6776
The market for mycoplasma testing in the Asia Pacific region consists of countries like China, Japan, the Republic of Korea, India, Australia, and the rest of Asia Pacific. The Asia Pacific region is projected to be the fastest-growing region due to the increasing adoption of these products.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
